Literature DB >> 23514183

Borderline personality disorder in four different age groups: a cross-sectional study of community residents in Germany.

Elisabeth A Arens1, Malte Stopsack, Carsten Spitzer, Katja Appel, Manuela Dudeck, Henry Völzke, Hans Jörgen Grabe, Sven Barnow.   

Abstract

Studies examining the natural course of borderline personality disorder (BPD) over the life span have yielded declining prevalence rates in older age groups. However, there is evidence that different BPD symptoms have different longitudinal patterns, with impulsivity decreasing with advancing age and negative affect remaining stable into late adulthood. However, since all studies dealt with treated, clinical samples of BPD patients, it is not yet known whether this represents the natural course of BPD symptoms or just mirrors difference in treatability of these symptoms. The authors addressed this issue by investigating a nonclinical population and compared prevalence of BPD, impulsivity, and depressivity in various age groups from adolescence to late adulthood (N = 2,488); all individuals were assessed by standardized clinical interviews. Syndromal and subsyndromal BPD rates sharply decreased between adolescents and young adults and remained stable thereafter. Whereas the same course was found for impulsivity, depressivity increased between young, middle-aged, and older adults. The present results support the hypothesis that age-related decreases in BPD diagnosis might be attributable to declining levels of impulsivity, whereas the persistence of a subsyndromal BPD might be attributable to an enduring negative affect.

Entities:  

Mesh:

Year:  2013        PMID: 23514183     DOI: 10.1521/pedi.2013.27.2.196

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  9 in total

Review 1.  The Lifetime Course of Borderline Personality Disorder.

Authors:  Robert S Biskin
Journal:  Can J Psychiatry       Date:  2015-07       Impact factor: 4.356

Review 2.  Impulsivity and Cluster B Personality Disorders.

Authors:  Daniel Turner; Alexandra Sebastian; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

3.  Probable Post-traumatic Stress Disorder and Self-harming Behaviour: Potential Barriers to Employment?

Authors:  J S Hansen; E Simonsen
Journal:  Community Ment Health J       Date:  2017-11-14

Review 4.  Prevalence of Borderline Personality Disorder in University Samples: Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Rebecca Meaney; Penelope Hasking; Andrea Reupert
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

5.  Quality of life in borderline patients comorbid with anxiety spectrum disorders - a cross-sectional study.

Authors:  Ales Grambal; Jan Prasko; Dana Kamaradova; Klara Latalova; Michaela Holubova; Zuzana Sedláčková; Radovan Hruby
Journal:  Patient Prefer Adherence       Date:  2016-08-01       Impact factor: 2.711

6.  Prevalence rates of borderline personality disorder symptoms: a study based on the Netherlands Mental Health Survey and Incidence Study-2.

Authors:  Margreet Ten Have; Roel Verheul; Ad Kaasenbrood; Saskia van Dorsselaer; Marlous Tuithof; Marloes Kleinjan; Ron de Graaf
Journal:  BMC Psychiatry       Date:  2016-07-19       Impact factor: 3.630

Review 7.  Early Detection and Outcome in Borderline Personality Disorder.

Authors:  Paola Bozzatello; Silvio Bellino; Marco Bosia; Paola Rocca
Journal:  Front Psychiatry       Date:  2019-10-09       Impact factor: 4.157

8.  Iconic Therapy for the reduction of borderline personality disorder symptoms among suicidal youth: a preliminary study.

Authors:  Fermín Mayoral; Rosa M Bersabé; Silvia Hurtado-Santiago; José Guzmán-Parra
Journal:  BMC Psychiatry       Date:  2022-03-29       Impact factor: 3.630

9.  Development of a screening algorithm for borderline personality disorder using electronic health records.

Authors:  Chengxi Zang; Marianne Goodman; Zheng Zhu; Lulu Yang; Ziwei Yin; Zsuzsanna Tamas; Vikas Mohan Sharma; Fei Wang; Nan Shao
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.